Givaudan SA Vs. Royalty Pharma PLC Industry Stock Comparison

Buy

66

GVDNY
Givaudan SA

Last Price:

$89.43

Seasonality Move:

4.79%

Sell

28

RPRX
Royalty Pharma PLC

Last Price:

$31.79

Seasonality Move:

-2.74%

Buy

66

Givaudan SA (GVDNY) is a Buy

Is Givaudan SA a Buy, Sell or Hold?

The current Givaudan SA [GVDNY] share price is $86.53. The Score for GVDNY is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
GVDNY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

28

Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

The current Royalty Pharma PLC [RPRX] share price is $31.28. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GVDNY Stock Price Chart

What is Givaudan SA's stock price today?

The Givaudan SA share price today is $86.53

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GVDNY is experiencing slight buying pressure.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

The Royalty Pharma PLC share price today is $31.28

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

GVDNY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.68	Sell
Relative Strength Index (14 RSI):	44.16	Sell
Chaikin Money Flow:	4794	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(86.94 - 91.18)	Sell
Bollinger Bands (100):	(85.81 - 90.17)	Sell

RPRX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.29	Sell
Relative Strength Index (14 RSI):	35.96	Sell
Chaikin Money Flow:	3261864	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(31.92 - 33.72)	Sell
Bollinger Bands (100):	(26.13 - 32.75)	Buy

GVDNY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	86.37	Buy
20-day SMA:	88.72	Sell
50-day SMA:	87.96	Sell
200-day SMA:	93.85	Sell
8-day EMA:	86.85	Sell
20-day EMA:	87.86	Sell
50-day EMA:	88.29	Sell
200-day EMA:	90.01	Sell

RPRX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	31.96	Sell
20-day SMA:	32.63	Sell
50-day SMA:	32.45	Sell
200-day SMA:	28.5	Buy
8-day EMA:	31.79	Sell
20-day EMA:	32.35	Sell
50-day EMA:	31.81	Sell
200-day EMA:	29.5	Buy

Givaudan SA Earnings Growth & GVDNY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.18 per share, an increase this year of $0.62 per share, and an increase next year of $0.31 per share.

Givaudan SA Technical Analysis

	Mar 20	Mar 21	Mar 24	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	21	24	25	26	27	28	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Royalty Pharma PLC Technical Analysis

	Mar 20	Mar 21	Mar 24	Mar 25	Mar 26	Mar 27	Mar 28	Mar 31	Apr 1	Apr 2
	Mar									Apr
	20	21	24	25	26	27	28	31	01	02
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):